(Q40568036)

21 September 2017

Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo (English)

1 reference

21 September 2017

1 reference

8

1 reference

21 September 2017

Alexandra Sullivan

1

1 reference

21 September 2017

Nelofer Syed

2

1 reference

21 September 2017

Milena Gasco

3

1 reference

21 September 2017

Daniele Bergamaschi

4

1 reference

21 September 2017

Giuseppe Trigiante

5

1 reference

21 September 2017

Marlene Attard

6

1 reference

21 September 2017

Louise Hiller

7

1 reference

21 September 2017

Paul Smith

9

1 reference

21 September 2017

Xin Lu

10

1 reference

21 September 2017

Tim Crook

11

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

21 September 2017

1 reference

21 September 2017

23

1 reference

21 September 2017

3328-3337

1 reference

21 September 2017

19

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207428

21 September 2017

0 references

cites work

The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207428

7 January 2021

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207428

7 January 2021

Apoptosis: a link between cancer genetics and chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207428

7 January 2021

Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207428

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207428

7 January 2021

p53 status and the efficacy of cancer therapy in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207428

7 January 2021

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207428

7 January 2021

p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207428

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207428

7 January 2021

Dissecting p53 tumor suppressor functions in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207428

7 January 2021

p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207428

7 January 2021

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207428

7 January 2021

Live or let die: the cell's response to p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207428

7 January 2021

PUMA mediates the apoptotic response to p53 in colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207428

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207428

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference